These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32543743)

  • 1. Psychodermatological mechanisms of psoriasis.
    Torales J; Echeverría C; Barrios I; García O; O'Higgins M; Castaldelli-Maia JM; Ventriglio A; Jafferany M
    Dermatol Ther; 2020 Nov; 33(6):e13827. PubMed ID: 32543743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities.
    Yang J; Zhang S; Wu Q; Chen P; Dai Y; Long J; Wu Y; Lin Y
    J Autoimmun; 2024 Apr; 144():103176. PubMed ID: 38364575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mind Body Connection in Dermatologic Conditions: A Literature Review.
    Mar K; Rivers JK
    J Cutan Med Surg; 2023 Nov; 27(6):628-640. PubMed ID: 37898903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis.
    Lakshmy S; Balasundaram S; Sarkar S; Audhya M; Subramaniam E
    Indian J Psychol Med; 2015; 37(4):434-40. PubMed ID: 26702177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychodermatology of Chronic Pruritus: An Overview of the Link Between Itch and Distress.
    Ferreira BR; Katamanin OM; Jafferany M; Misery L
    Dermatol Ther (Heidelb); 2024 Jul; 14(7):1799-1809. PubMed ID: 38914907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.
    Bu J; Ding R; Zhou L; Chen X; Shen E
    Front Immunol; 2022; 13():880201. PubMed ID: 35757712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis: What Is New in Markers of Disease Severity?
    Tampa M; Mitran MI; Mitran CI; Matei C; Georgescu SR
    Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399624
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk Factors for Psoriasis Flares: A Narrative Review.
    Potestio L; Lauletta G; Tommasino N; Portarapillo A; Salsano A; Battista T; Martora F; Megna M
    Psoriasis (Auckl); 2024; 14():39-50. PubMed ID: 38831846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Psoriasis on Patients' Social Network Behavior.
    Li YM; Galimberti F
    South Med J; 2024 Feb; 117(2):115. PubMed ID: 38307510
    [No Abstract]   [Full Text] [Related]  

  • 10. Correction to 'Classification of psychodermatological disorders: Proposal of a new international classification'.
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1213-1214. PubMed ID: 38682704
    [No Abstract]   [Full Text] [Related]  

  • 11. Association Between Psoriasis and Depression: A Traditional Review.
    Sahi FM; Masood A; Danawar NA; Mekaiel A; Malik BH
    Cureus; 2020 Aug; 12(8):e9708. PubMed ID: 32944430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of psychocutaneous disorders: A practical approach for dermatologists.
    Jafferany M; Ferreira BR; Abdelmaksoud A; Mkhoyan R
    Dermatol Ther; 2020 Nov; 33(6):e13969. PubMed ID: 32621633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Treatment Addressing the Pathogenesis of Psoriasis.
    Tokuyama M; Mabuchi T
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and Cellular Mechanisms of Itch in Psoriasis.
    Komiya E; Tominaga M; Kamata Y; Suga Y; Takamori K
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression.
    Wang X; Li Y; Wu L; Xiao S; Ji Y; Tan Y; Jiang C; Zhang G
    Biomed Pharmacother; 2021 May; 137():111065. PubMed ID: 33540138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis.
    Griffiths CEM; Armstrong AW; Gudjonsson JE; Barker JNWN
    Lancet; 2021 Apr; 397(10281):1301-1315. PubMed ID: 33812489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and factors associated with depression and anxiety in patients with psoriasis.
    Pollo CF; Miot HA; Matos TDS; de Souza JM; Jorge MFS; Miot LDB; Meneguin S
    J Clin Nurs; 2021 Feb; 30(3-4):572-580. PubMed ID: 33258200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the impact of depression on the treatment of psoriasis.
    Bell KA; Balogh EA; Feldman SR
    Expert Opin Pharmacother; 2021 Apr; 22(6):695-703. PubMed ID: 33198529
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.
    Petit RG; Cano A; Ortiz A; Espina M; Prat J; Muñoz M; Severino P; Souto EB; García ML; Pujol M; Sánchez-López E
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review.
    von Stülpnagel CC; Augustin M; Düpmann L; da Silva N; Sommer R
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):2166-2184. PubMed ID: 33988873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.